Arena Pharmaceuticals Product Candidates

Product Candidates

Robust pipeline of innovative oral drugs for large markets

Arena Pharmaceuticals
Product Candidates

Product Candidates

Robust pipeline of innovative oral drugs for large markets




APD916: Wakefulness Promoter
Niacin Receptor Agonist: Atherosclerosis

GPCR Modulator: Psychiatric Disorder

















*Representative of Arena's research programs

Our product candidates have not been approved by the U.S. Food and Drug Administration or any international regulatory agency.

(NOTE: This page was last updated: June 5, 2008.)

Back To Top

---
Copyright 2007
Terms and Conditions | Privacy Statement
  Contact Us  Site Map |   Search